These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 9587932)

  • 21. Chemosensitivity of advanced larynx carcinoma cells in vitro and significance of multidrug resistance markers in these tumors.
    Juvekar AS; Amonkar AJ; D'cruz AK; Saikaia T; Pradhan S
    Cancer Biother Radiopharm; 1998 Apr; 13(2):81-7. PubMed ID: 10850344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Expression of P-glycoprotein as a multidrug resistance gene product in human reactive astrocytes and astrocytoma].
    Dietzmann K; Bossanyi PV; Franke DS
    Zentralbl Pathol; 1994 Jul; 140(2):149-53. PubMed ID: 7947620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sinomenine reverses multidrug resistance in bladder cancer cells via P-glycoprotein-dependent and independent manners.
    Chen Y; Zhang L; Lu X; Wu K; Zeng J; Gao Y; Shi Q; Wang X; Chang LS; He D
    Pharmazie; 2014 Jan; 69(1):48-54. PubMed ID: 24601223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene transfer of human TNF alpha into glioblastoma cells permits modulation of mdr1 expression and potentiation of chemosensitivity.
    Walther W; Stein U; Pfeil D
    Int J Cancer; 1995 Jun; 61(6):832-9. PubMed ID: 7790119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Flow cytometry for testing chemosensitivity of malignant bone tumors].
    Zeng J; Hu Y; Pei F; Lei S; Mao Y; Wei Y
    Zhonghua Wai Ke Za Zhi; 1999 Dec; 37(12):737-9. PubMed ID: 11829940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis Suggests Drug Combos for Glioblastoma.
    Cancer Discov; 2016 Jun; 6(6):OF2. PubMed ID: 27165727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current trends in the chemotherapy of brain tumors with special reference to glioblastomas.
    Wilson CB; Hoshino T
    J Neurosurg; 1969 Dec; 31(6):589-603. PubMed ID: 4311657
    [No Abstract]   [Full Text] [Related]  

  • 28. Can in-vitro chemoresponse assays help find new treatment regimens for malignant gliomas?
    Linz U; Ulus B; Neuloh G; Clusmann H; Oertel M; Nolte K; Weis J; Heussen N; Gilsbach JM
    Anticancer Drugs; 2014 Apr; 25(4):375-84. PubMed ID: 24423983
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemosensitivity of malignant human brain tumors. Preliminary results.
    Bogdahn U
    J Neurooncol; 1983; 1(2):149-66. PubMed ID: 6088712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emerging therapeutic targets and agents for glioblastoma therapy - part I.
    Lo HW
    Anticancer Agents Med Chem; 2010 Jul; 10(6):437. PubMed ID: 20937018
    [No Abstract]   [Full Text] [Related]  

  • 31. Development of a novel in vitro chemosensitivity assay: telomerase as a possible marker of tumor cell survival.
    Faraoni I; Turriziani M; Bonmasssar E; De Vecchis L; Graziani G
    J Chemother; 1996 Oct; 8(5):394-8. PubMed ID: 8957721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and in vitro cytotoxicity of haloderivatives of noscapine.
    Verma AK; Bansal S; Singh J; Tiwari RK; Kasi Sankar V; Tandon V; Chandra R
    Bioorg Med Chem; 2006 Oct; 14(19):6733-6. PubMed ID: 16784870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Revisiting Platinum-Based Anticancer Drugs to Overcome Gliomas.
    Jeon J; Lee S; Kim H; Kang H; Youn H; Jo S; Youn B; Kim HY
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemosensitivity of glioma cells in vitro: a meta analysis.
    Wolff JE; Trilling T; Mölenkamp G; Egeler RM; Jürgens H
    J Cancer Res Clin Oncol; 1999; 125(8-9):481-6. PubMed ID: 10480340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. P-glycoprotein--a marker of cancer-cell behavior.
    Pinedo HM; Giaccone G
    N Engl J Med; 1995 Nov; 333(21):1417-9. PubMed ID: 7477126
    [No Abstract]   [Full Text] [Related]  

  • 36. In vitro assays for the evaluation of drug resistance in tumor cells.
    Hatok J; Babusikova E; Matakova T; Mistuna D; Dobrota D; Racay P
    Clin Exp Med; 2009 Mar; 9(1):1-7. PubMed ID: 18818983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Methods for investigation and estimation of individual chemosensitivity of tumors (review)].
    Pashkova VS; Filippova LA; Lavrenov AL
    Antibiot Khimioter; 1995 Apr; 40(4):45-51. PubMed ID: 7654101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent Advancements and Strategies for Overcoming the Blood-Brain Barrier Using Albumin-Based Drug Delivery Systems to Treat Brain Cancer, with a Focus on Glioblastoma.
    Tincu Iurciuc CE; Andrițoiu CV; Popa M; Ochiuz L
    Polymers (Basel); 2023 Oct; 15(19):. PubMed ID: 37836018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel Treatment Approaches for Brain Tumour from a Blood-Brain Barrier Perspective.
    Wu SK; Tsai CL; Hynynen K
    Handb Exp Pharmacol; 2022; 273():351-364. PubMed ID: 33454856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain/brain tumor barriers for glioblastoma treatment.
    Wang D; Wang C; Wang L; Chen Y
    Drug Deliv; 2019 Dec; 26(1):551-565. PubMed ID: 31928355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.